Onyx Pharmaceuticals, Inc. (ONXX: Quote) is surging over 37 percent to $61.27. The company announced that the FDA's Oncologic Drugs Advisory Committee has determined that in patients with relapsed and refractory multiple myeloma who have received at least two prior lines of therapy that included a proteasome inhibitor and an immunomodulatory agent, the benefit-risk assessment is favorable for the use of Kyprolis.
ConAgra Foods, Inc. (CAG: Quote) is rising more than 1 percent to $24.88. The company slipped to a loss in its fourth quarter. However, adjusted earning per share from continuing operations improved 9 percent, and topped Wall Street view. The company said it expects expect good earnings growth in fiscal 2013.
Rite Aid Corp. (RAD: Quote) is up 5 percent to $1.23. The company's first quarter loss narrowed from the previous year period. Revenues improved from the year-ago quarter and topped the consensus estimate. Same store sales for the quarter rose 2.5 percent.
Sun Healthcare Group Inc. (SUNH: Quote) is jumping 36 percent to $8.35. The company has agreed to be acquired by Genesis Healthcare for $8.50 per share, in cash, resulting in about $275 million net of cash and debt acquired.
Celgene Corp. (CELG: Quote) is declining 10 percent to $60.19. The company has decided to withdraw the new indication submission to the Committee for Medicinal Products for Human Use for REVLIMID (lenalidomide), which was intended for the maintenance treatment of newly diagnosed multiple myeloma patients who have not progressed following initial treatment with melphalan, prednisone and REVLIMID (lenalidomide), or maintenance therapy following autologous stem cell transplantation.
Red Hat, Inc. (RHT: Quote) is falling 10 percent to $50.90. The company's first quarter profit improved 15 percent from the year-ago quarter. Total revenue for the quarter rose 19 percent and also topped the consensus estimate. However, the company's quarterly billings missed some analysts' estimates.
Bed Bath & Beyond Inc. (BBBY: Quote) is declining 10 percent to $66.15. The company's first quarter profit and sales increased from the year-ago period. Earnings per share were above the Wall Street view, but sales missed the consensus estimate. Meanwhile, the company provided a weak earnings outlook for its second quarter.
Philip Morris International Inc. (PM: Quote) is down over 1 percent to $87.04. The company lowered, for prevailing exchange rates only, its full-year reported earnings per share forecast.
| || |
| To receive FREE breaking news email alerts for Bed Bath & Beyond Inc and others in your portfolio|
by RTT Staff Writer
For comments and feedback: email@example.com